Trial Profile
Comparison of Efonidipine/Irbesartan combination and Irbesartan monotherapy for uncontrolled hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Efonidipine (Primary) ; Irbesartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 30 Jul 2011 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 07 Sep 2009 New trial record